{"id":"W2848978533","doi":"10.1016/j.jacc.2018.04.054","title":"The Evolving Future of PCSK9 Inhibitors","year":2018,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":264,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University","funders":"","keywords":"PCSK9; Medicine; Ezetimibe; Proprotein convertase; Kexin; Clinical trial; Coronary artery disease; Internal medicine; Monoclonal antibody; Disease; Acute coronary syndrome; Cholesterol; LDL receptor; Pharmacology; Lipoprotein; Antibody; Immunology; Myocardial infarction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002762088,0.0003051394,0.005169921,0.0002023412,0.0001331895,0.000004279071,0.0007143325,0.0002096532,0.000004756031],"category_scores_gemma":[0.0005258615,0.0001326486,0.0049216,0.0007775298,0.001123021,0.00002895844,0.000193015,0.0008877866,0.000001996881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002056881,"about_ca_system_score_gemma":0.002018652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001537304,"about_ca_topic_score_gemma":0.000002950836,"domain_scores_codex":[0.995819,0.001333094,0.001588984,0.0001861729,0.0007563859,0.0003163502],"domain_scores_gemma":[0.9932743,0.0003858629,0.004240985,0.001139202,0.0008265899,0.0001330727],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002747731,0.00003350211,0.0002233046,0.006305407,0.008090408,0.0001955159,0.00003201949,0.000003907326,0.000009888679,0.0001536819,0.06458915,0.9200885],"study_design_scores_gemma":[0.000353955,0.001019032,0.00026378,0.004669309,0.003217381,0.00708368,0.0003352696,4.358798e-7,0.00001069983,0.00003386962,0.9829066,0.0001060229],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006788635,0.9946676,0.00002765372,0.0006951104,0.002333892,0.0006515261,0.00006203813,0.000003642137,0.0008796116],"genre_scores_gemma":[0.002376465,0.9887756,0.0002589131,0.00007061436,0.008303482,0.00000867269,0.000001073442,0.00004511195,0.0001601461],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9199824,"threshold_uncertainty_score":0.5409254,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01722825365685192,"score_gpt":0.30324153793483,"score_spread":0.2860132842779781,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}